Literature DB >> 8135041

Metabolism of caffeine and theophylline in rats with malaria and endotoxin-induced fever.

G O Kokwaro1, I S Szwandt, A P Glazier, S A Ward, G Edwards.   

Abstract

1. The effects of malaria infection due to Plasmodium berghei and Escherichia coli endotoxin-induced fever on the metabolism of orally-administered caffeine (CA: 10 mg/kg) to its primary metabolites (theobromine (TB), paraxanthine (PX) and theophylline (TH)) were studied in 5-week-old male Wistar rats (n = 5 for each treatment). In separate experiments, the effects of malaria and endotoxin-induced fever on the clearance of i.v.-administered theophylline (TH; 15 mg/kg) were studied in another group of rats. 2. The ratios of CA to the three primary metabolites (TB/CA, PX/CA, PH/CA) determined in a single plasma sample obtained 3 h after CA administration were significantly reduced (p < 0.05) both by malaria and fever compared with control (saline) treatment. The clearance of TH determined from the concentration of TH in a single plasma sample obtained 6 h after TH administration was significantly reduced (p < 0.05) by fever but not malaria (4.0 +/- 0.7 ml/min/kg in controls; 4.2 +/- 0.5 in malaria; 2.4 +/- 0.4 in fever). 3. These results suggest that malaria and fever have different effects on CA and TH metabolism in vivo, probably as a result of different effects on the hepatic isozymes involved.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8135041     DOI: 10.3109/00498259309059448

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  2 in total

Review 1.  Recent advances in caffeine and theobromine toxicities: a review.

Authors:  M U Eteng; E U Eyong; E O Akpanyung; M A Agiang; C Y Aremu
Journal:  Plant Foods Hum Nutr       Date:  1997       Impact factor: 3.921

2.  Effects of Plasmodium berghei infection on cytochromes P-450 2E1 and 3A2.

Authors:  K Uhl; J M Grace; D A Kocisko; B T Jennings; A L Mitchell; T G Brewer
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1999 Apr-Jun       Impact factor: 2.569

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.